SOX2 and breast cancer: Another support of the notion that most of the Sox2-positive cells in the CAF-CM-treated sublines are non-CSCs comes from the observation that siSox2 induced a strong decline in the level of ERα, which is primarily expressed in non-CSCs, as shown for the MCF-7 cell line as well as for ERα-positive primary breast cancer [22,66].